2025 Annual Shareholders' Meeting Results

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

2025 Annual Shareholders’ Meeting Results

Auckland, New Zealand, 21 August 2025 – Fisher & Paykel Healthcare Corporation Limited advises
that all resolutions put to the company’s annual shareholders’ meeting held today were passed.
The seven resolutions were:
Resolution 1: To re-elect Neville Mitchell as a Director.
Resolution 2: To re-elect Lewis Gradon as a Director.
Resolution 3: To re-elect Lisa McIntyre as a Director.
Resolution 4: To re-elect Cather Simpson as a Director.
Resolution 5: To elect Mark Cross as a Director.
Resolution 6: To authorise the Directors to fix the fees and expenses of the company’s auditor.
Resolution 7: To approve the grant of discretionary long term variable remuneration instruments to
Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2025.
All resolutions were decided by poll. The details of the total number of votes cast online, in person or by
proxy on the polls were as follows:

Resolution For Against Abstain
Resolution 1: Re-election of
Neville Mitchell
429,216,814
97.36%
11,652,978
2.64%
1,299,617
Resolution 2: Re-election of
Lewis Gradon
441,426,824
99.97%
139,173
0.03%
601,896
Resolution 3: Re-election of
Lisa McIntyre
430,486,886
97.37%
11,642,888
2.63%
39,635
Resolution 4: Re-election of
Cather Simpson
441,889,235
99.95%
243,087
0.05%
37,087
Resolution 5: Election of
Mark Cross
437,480,939
98.98%
4,489,818
1.02%
198,652
Resolution 6: Approval of
auditors’ fees and expenses
437,099,574
99.05%
4,211,623
0.95%
858,212
Resolution 7: Grant of
discretionary long term
variable remuneration
instruments to Lewis
Gradon
431,000,052
97.82%
9,625,215
2.18%
963,529

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems
for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The
company’s products are sold in over 120 countries worldwide. For more information about the company,
visit our website www.fphcare.com.

Contacts

Media Investors
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 (0) 21 713 911
Dan Adolph
Head of Investor Relations
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050



Authorised by Raelene Leonard, General Counsel & Company Secretary.